Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: A multi-center, open-label, randomized controlled trial
- Usha S. Perepu
- , Isaac Chambers
- , Abdul Wahab
- , Patrick Ten Eyck
- , Chaorong Wu
- , Sanjana Dayal
- , Grerk Sutamtewagul
- , Steven R. Bailey
- , Lori J. Rosenstein
- , Steven R. Lentz
Research output: Contribution to journal › Article › peer-review
128
!!Link opens in a new tab
Scopus
citations